Document is current
Any future updates will be listed below
-
Authors
Terradas, Mariona
Mur, Pilar
Morón-Duran, Francisco D.
Mengod, Pol
Löffler, Chiara M. L.
Helderman, Noah C.
Terlouw, Diantha
Sanjuán, Xavier
Bousquets-Muñoz, Pablo
Viana-Errasti, Julen
Puente, Xose S.
Capellá, Gabriel
Nielsen, Maartje
van Wezel, Tom
Kather, Jakob Nikolas
Lázaro, Conxi
Moreno, Victor
Valle, Laura
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (CIBERONC CB16/12/00234 and PMP22/00064, CIBERONC CB16/12/00234 and PMP22/00064, CIBERONC CB16/12/00234 and PMP22/00064, CIBERONC CB16/12/00234 and PMP22/00064, CIBERONC CB16/12/00234 and PMP22/00064, CIBERONC CB16/12/00234 and PMP22/00064)
Generalitat de Catalunya (AGAUR 2021SGR01112 and CERCA Program, AGAUR 2021SGR01112 and CERCA Program, AGAUR 2021SGR01112 and CERCA Program, AGAUR 2021SGR01112 and CERCA Program, AGAUR 2021SGR01112 and CERCA Program)
Fundación Científica Asociación Española Contra el Cáncer (AECC Investigador)
Agencia Estatal de Investigación (PID2020-112595RB-I00, AEI/10.13039/501100011033, PID2020-112595RB-I00, AEI/10.13039/501100011033, PID2020-112595RB-I00, AEI/10.13039/501100011033, PID2020-112595RB-I00, AEI/10.13039/501100011033)
- License Information
-
More Information
Article History
Received: 6 February 2025
Accepted: 16 June 2025
First Online: 5 November 2025
Declarations
:
: The study received the approvals of the Ethics Committee of the Bellvitge Biomedical Research Centre (IDIBELL, Spain) (Protocol PR073/12), and the Medical Ethical Committee of the Leiden University Medical Centre (LUMC, The Netherlands) (Protocol P01.019).
: JNK declares consulting services for Bioptimus, France; Owkin, France; DoMore Diagnostics, Norway; Panakeia, UK; AstraZeneca, UK; Scailyte, Switzerland; Mindpeak, Germany; and MultiplexDx, Slovakia. Furthermore, he holds shares in StratifAI GmbH, Germany, Synagen GmbH, Germany, and has received a research grant by GSK, and has received honoraria by AstraZeneca, Bayer, Daiichi Sankyo, Eisai, Janssen, MSD, BMS, Roche, Pfizer, and Fresenius. The other authors declare no conflicts of interest.
